MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2215/cjn.0000000676

Медицинская библиотека · Clinical journal of the American Society of Nephrology : CJASN · 2025

Defining Kidney Health Dimensions and Their Associations with Adverse Outcomes in Persons with Diabetes and CKD.

Peschard Vanessa-Giselle, Scherzer Rebecca, Estrella Michelle M, Sarnak Mark J, Ascher Simon B, Lash James, Bonventre Joseph V, Greenberg Jason H, Gutierrez Orlando M, Schelling Jeffrey R, Katz Ronit, Cheung Katharine L, Levitan Emily B, Schrauben Sarah J, Cushman Mary, Ilori Titilayo O, Parikh Chirag R, Kimmel Paul L, Rao Panduranga S, Taliercio Jonathan J, Sondheimer James, Shulman Rachel, Coca Steven G, Chen Jing, Ramachandran Vasan S, Ix Joachim H, Shlipak Michael G, CKD Biomarkers Consortium and the Chronic Renal Insufficiency Cohort (CRIC) Study Investigators

СтатьяПеревод в очереди

Аннотация

KEY POINTS: We identified three kidney health dimensions using 17 urine and plasma biomarkers across two cohorts of persons with diabetes and CKD. Worse scores for tubule injury, tubule function, and systemic inflammation/filtration were associated with a higher risk of CKD progression and death. A multibiomarker approach could help capture tubulointerstitial health in persons with diabetes and CKD.

BACKGROUND

Individual kidney tubule biomarkers are associated with risks of CKD progression and mortality in persons with diabetes. Integrating multiple kidney biomarkers using a latent variable method of exploratory factor analysis could define distinct dimensions of kidney health and their associations with adverse outcomes.

METHODS

We conducted a factor analysis of 17 candidate urine and plasma biomarkers in 1256 participants with diabetes and eGFR <60 ml/min per 1.73 m2 from the Chronic Renal Insufficiency Cohort (CRIC; N=701) and the REasons for Geographic And Racial Differences in Stroke (REGARDS; N=555) studies. We used Cox proportional hazards models to evaluate the associations of identified factors with CKD progression and mortality, adjusting for baseline clinical risk factors, eGFR, and albuminuria.

RESULTS

Three factor scores comprising ten biomarkers were identified: systemic inflammation and filtration (plasma TNF receptor-1 and TNF receptor-2, plasma soluble urokinase plasminogen activator receptor, and plasma symmetric dimethylarginine), tubular function (urine EGF, urine asymmetric dimethylarginine, and urine symmetric dimethylarginine), and tubular damage (urine α-1 microglobulin, urine kidney injury molecule-1, and urine monocyte chemoattractant protein-1). In CRIC, there were 244 incident ESKD events, 102 with ≥40% eGFR decline from baseline, and 259 deaths; in REGARDS, there were 121 incident ESKD events and 462 deaths. In CRIC, lower tubular function (hazard ratio per 1-SD, 0.36; 95% confidence interval, 0.25 to 0.52) and higher tubular damage (1.45; 1.18 to 1.78) scores were independently associated with higher CKD progression risk. Associations in REGARDS were weaker but directionally consistent (tubular function score [0.81; 0.47 to 1.39] and tubular damage score [1.12; 0.73 to 1.72]). Higher tubular damage (1.47; 1.15 to 1.87) scores were associated with higher mortality risk in CRIC, but not REGARDS (1.15; 0.96 to 1.38). Higher systemic inflammation and filtration factor scores were associated with higher mortality risk in both cohorts (CRIC: 1.35; 1.07 to 1.71; REGARDS: 1.41; 1.20 to 1.65).

CONCLUSIONS

Three distinct kidney health dimensions were identified, and each associated with CKD progression and/or all-cause mortality in persons with diabetes and CKD.

Для цитирования: Peschard Vanessa-Giselle, Scherzer Rebecca, Estrella Michelle M, Sarnak Mark J, Ascher Simon B, Lash James, Bonventre Joseph V, Greenberg Jason H, Gutierrez Orlando M, Schelling Jeffrey R, Katz Ronit, Cheung Katharine L, Levitan Emily B, Schrauben Sarah J, Cushman Mary, Ilori Titilayo O, Parikh Chirag R, Kimmel Paul L, Rao Panduranga S, Taliercio Jonathan J, Sondheimer James, Shulman Rachel, Coca Steven G, Chen Jing, Ramachandran Vasan S, Ix Joachim H, Shlipak Michael G, CKD Biomarkers Consortium and the Chronic Renal Insufficiency Cohort (CRIC) Study Investigators. Defining Kidney Health Dimensions and Their Associations with Adverse Outcomes in Persons with Diabetes and CKD.. Clinical journal of the American Society of Nephrology : CJASN. 2025. DOI: 10.2215/cjn.0000000676.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.